Literature DB >> 21552814

Comparison of 4 proliferation markers and their significance for evaluation of tumor dignity in intracranial tumors.

C Hagel1, P Schwartz, R Laas, D Stavrou.   

Abstract

The proliferation indices of immunohistochemically detected bromodeoxyuridine, Ki-67 antigen (antibodies Ki-67 and MIB 1), and proliferating cell nuclear antigen were determined manually and with computer assisted morphometry in 38 gliomas, 29 meningeomas, 9 metastases, and 16 other tumors. Comparing the markers among one another the highest correlation coefficient was found for bromodeoxyuridine and MIB 1 (0.9). The proliferation indices of all markers correlated significantly with the tumor grading. The highest correlation coefficient for proliferation index and grading (0.7) was calculated for the MIB 1 index determined in one high power field (0.0153 mm(2)) in the tissue area with the highest proliferative activity. Concerning applicability and correlation with tumor dignity MIB 1 was superior to the other three antibodies investigated.

Entities:  

Year:  1995        PMID: 21552814     DOI: 10.3892/ijo.7.1.107

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Effect of Ribonuclease A and Deoxyribonuclease I on Immunostaining of Ki-67 in Cultured Melanoma Cells.

Authors:  Jamal Benfares; Agnés Le Tourneau; Josée Audouin; György Szekeres
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas.

Authors:  E Patsouris; R Laas; C Hagel; D Stavrou
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

3.  CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas.

Authors:  Christian Hagel; Sung-Ho Park; Maximilian J A Puchner; Dimitrios Stavrou
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.